SecSonar.com

Wave Life Sciences Ltd. (WVE)

Wave Life Sciences Ltd. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Wave Life Sciences Ltd. (WVE) is a Biotechnology company based in SG with a market capitalization of $1.3B. Revenue declined 60.5% year-over-year and free cash flow was negative at -$188.2M. This page tracks WVE's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

SG · 287 employees · IPO Nov 11, 2015

Valuation

Valuation & price

$6.77 · as of May 17, 2026 · -68.2% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

2.42

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$20.23$12.98$5.73Jul 25Dec 25Jul 26Jul 7, 25$7.06Jul 9, 25$7.70Jul 11, 25$7.70Jul 15, 25$7.71Jul 17, 25$8.01Jul 21, 25$7.87Jul 23, 25$8.56Jul 25, 25$8.40Jul 29, 25$8.32Jul 31, 25$8.10Aug 4, 25$8.75Aug 6, 25$8.55Aug 11, 25$8.11Aug 13, 25$8.76Aug 15, 25$9.76Aug 19, 25$9.51Aug 21, 25$9.76Aug 25, 25$9.94Aug 27, 25$10.08Aug 29, 25$9.60Sep 3, 25$8.00Sep 5, 25$8.29Sep 9, 25$7.48Sep 11, 25$7.16Sep 16, 25$6.82Sep 18, 25$6.96Sep 22, 25$6.91Sep 24, 25$6.73Sep 26, 25$6.80Sep 30, 25$7.32Oct 2, 25$7.02Oct 6, 25$7.22Oct 8, 25$7.35Oct 10, 25$7.60Oct 14, 25$7.89Oct 16, 25$7.87Oct 21, 25$7.85Oct 23, 25$7.05Oct 27, 25$7.62Oct 29, 25$8.26Oct 31, 25$9.04Nov 4, 25$8.01Nov 6, 25$7.88Nov 10, 25$7.05Nov 12, 25$6.96Nov 14, 25$7.08Nov 18, 25$7.11Nov 20, 25$6.76Nov 25, 25$7.43Nov 28, 25$7.76Dec 2, 25$6.99Dec 4, 25$7.62Dec 8, 25$18.52Dec 10, 25$20.23Dec 12, 25$16.56Dec 16, 25$16.41Dec 18, 25$15.54Dec 22, 25$17.97Dec 24, 25$18.25Dec 29, 25$17.86Jan 2, 26$15.95Jan 6, 26$15.15Jan 8, 26$14.83Jan 12, 26$13.91Jan 14, 26$14.51Jan 16, 26$13.65Jan 21, 26$13.94Jan 23, 26$13.47Jan 27, 26$13.36Jan 29, 26$13.01Feb 2, 26$13.43Feb 4, 26$13.33Feb 9, 26$13.67Feb 11, 26$13.27Feb 13, 26$12.68Feb 18, 26$13.09Feb 20, 26$13.49Feb 24, 26$14.02Feb 26, 26$15.36Mar 2, 26$13.85Mar 4, 26$13.71Mar 6, 26$13.12Mar 10, 26$13.75Mar 12, 26$13.35Mar 17, 26$12.46Mar 19, 26$12.12Mar 23, 26$11.62Mar 25, 26$12.30Mar 27, 26$6.37Mar 31, 26$7.25Apr 2, 26$7.28Apr 7, 26$7.10Apr 9, 26$7.16Apr 13, 26$7.26Apr 15, 26$7.59Apr 17, 26$7.49Apr 22, 26$7.38Apr 24, 26$7.18Apr 28, 26$7.52Apr 30, 26$7.06May 4, 26$7.47May 6, 26$7.29May 8, 26$7.18May 12, 26$6.79May 14, 26$6.90May 18, 26$6.40May 20, 26$6.19May 22, 26$6.38May 28, 26$6.47Jun 1, 26$6.26Jun 3, 26$5.76Jun 5, 26$5.73Jun 9, 26$5.78Jun 11, 26$5.81Jun 15, 26$6.00Jun 17, 26$5.95Jun 22, 26$6.17Jun 24, 26$5.95Jun 26, 26$5.83Jul 2, 26$6.26
$5.6652-week range$21.31
Loading valuation history…

Fundamentals

Key fundamentals

$1.3B

Market cap

-60.5%

Revenue growth (YoY)

79.3%

Gross margin

-$188.2M

Free cash flow (USD)

-$584.3M

Net debt

Net cash position

22.0%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$1.5MFY 2017$3.7MFY 2018$14.4MFY 2019$16.0MFY 2020$20.1MFY 2021$41.0MFY 2022$3.6MFY 2023$113.3MFY 2024$108.3MFY 2025$42.7M
$1.5M$42.7M

Free cash flow by year

2016 → 2025

FY 2016$-37.4MFY 2017$-102.6MFY 2018$-32.8MFY 2019$-192.1MFY 2020$-117.3MFY 2021$-89.6MFY 2022$-129.1MFY 2023$-20.5MFY 2024$-152.0MFY 2025$-188.2M
-$37.4M-$188.2M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 2022100.0%FY 2023100.0%FY 2024100.0%FY 202579.3%
100.0%79.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-K/A filed Apr 30, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventRedomiciliation ApprovedJun 26, 2026Filing
  • 8-K eventClinical Trial UpdateMay 18, 2026Filing
  • Annual report10-K FiledApr 30, 2026Filing
  • 8-K eventEarnings ReleaseApr 28, 2026Filing
  • Quarterly report10-Q FiledApr 28, 2026Filing
  • 8-K eventRedomiciliation HearingApr 21, 2026Filing
  • 8-K eventRedomiciliation AgreementApr 15, 2026Filing

Questions

Frequently asked questions

What is Wave Life Sciences Ltd.'s market cap?

Wave Life Sciences Ltd. (WVE) has a market capitalization of $1.3B.

What is WVE's P/E ratio?

A meaningful P/E ratio is not available for WVE — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is WVE's price-to-book (P/B) ratio?

WVE trades at 2.42 times book value per share.

Are insiders buying WVE stock?

SEC Form 4 filings show no open-market insider buys at Wave Life Sciences Ltd. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

GLUE

Monte Rosa Therapeutics, Inc.

$1.3B

NKTR

Nektar Therapeutics

$1.3B

PGEN

Precigen, Inc.

$1.3B

MRVI

Maravai LifeSciences Holdings, Inc.

$1.3B

SEPN

Septerna, Inc.

$1.4B

MNKD

MannKind Corporation

$1.2B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.